LifeScience Biologics

Stealth BioTherapeutics Corp Announces Completion of Merger

Stealth BioTherapeutics Corp (Nasdaq: MITO) (the "Company" or "Stealth BioTherapeutics"), a clinical-stage biotechnology company focused on the discov...

 November 17, 2022 | News

Monash University Implements Antibody Discovery Application by Utilizing the Berkeley Lights Beacon® Platform

The technology is housed in the Monash Antibody Technology Facility (MATF) where researchers not only from Monash University but elsewhere in Victoria...

 November 10, 2022 | News

XJTLU and University of Liverpool to inaugurate Joint Centre for Pharmacology and Therapeutics

Xi'an Jiaotong-Liverpool University (XJTLU) researchers conduct world-class biopharmaceutical research at the University's Suzhou Industrial Park (SIP) c...

 November 09, 2022 | News

Cyagen and Neurophth Enter Global Strategic Collaboration to Develop AI-Designed AAV Gene Therapy Vectors for Ophthalmic Disorders

Under the terms of the agreement, Cyagen will apply its proprietary artificial intelligence (AI)-powered high-throughput platform to discover novel AAV vec...

 November 08, 2022 | News

Brexogen's Exosome Therapy for Atopic Dermatitis, 'BRE-AD01' Accepted for Phase 1 Clinical Trials by US FDA

The US FDA granted the initiation of the phase 1 clinical trial of 'BRE-AD01', an exosome- based therapy for atopic dermatitis. 'BRE-AD01' is being develop...

 November 07, 2022 | News

I Peace partners with the California Institute for Regenerative Medicine [CIRM]

 I Peace has been providing GMP Induced Pluripotent Stem Cells (iPSC) for a variety of cell therapy developers and pharmaceutical companies in the pas...

 November 02, 2022 | News

Thermo Fisher Scientific to Acquire The Binding Site Group

Complements Existing Specialty Diagnostics Offering with Established Technologies Delivering Strong Clinical Value for Patients in a Rapidly Growing...

 November 01, 2022 | News

Register Now | Learn how Optimer ligands can be developed in a biomarker-free way to open up new targets for challenging diseases

    Speakers Dr David Bunka Chief Technical Officer Synopsis Dev...

 October 28, 2022 | News

Polyplus and ENcell sign MOU for gene therapy discovery and optimization projects in Korea

“ENCell is working to accelerate viral vector CMO business via a collaboration with Polyplus.”, said Dr. Jong Wook Chang, CEO of ENCell. &ldquo...

 October 28, 2022 | News

Aragen launches royalty-free CHO GS cell line development platform under RapTr2022

 Aragen Life Sciences (Aragen), a leading Contract Research, Development, and Manufacturing Organization (CRDMO), with eight facilities across In...

 October 28, 2022 | News

Agilent and Monash University Sign Agreement to Build Malaysia Integrated Biology Center

These R&D environments, focused on providing analytical expertise for both small and large molecules, will advance scientific knowledge on the developm...

 October 26, 2022 | News

EVIDENT Opens New Asia-Pacific Headquarters in Singapore

Evident announced the opening of its new Asia-Pacific (APAC)  headquarters in Singapore, marking its ongoing commitment to expand its business and&nbs...

 October 26, 2022 | News

Sartorius Enters Research Partnership with The BASE Facility at the University of Queensland

Sartorius entered a research partnership with The BASE Facility at The University of Queensland (UQ) to improve the manufacturing process of nucleic a...

 October 24, 2022 | News

Thermo Fisher Scientific Launches Closed and Automated Cell Isolation and Bead Removal Solution to Help Evolve Cell Therapy Manufacturing

Thermo Fisher Scientific Inc., the world leader in serving science, today unveiled the Gibco™ CTS™ DynaCellect™ Magnetic Separation ...

 October 21, 2022 | News


News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close